you are viewing a single comment's thread.
Why would it take 6 years? If the trials look good, it seems the FDA are looking to accelerate approvals for drugs like this.
Sorry, what I was referring to was the timeframe for a new combined drug (661 + Kalydeco + additional correctors) which would have a dramatic effect on the health of DD508 CF patients, to come to market.
Sentiment: Strong Buy
I agree - I think there is a push and that we could see this in two.